{"id":1299955,"date":"2025-09-08T07:13:12","date_gmt":"2025-09-08T01:43:12","guid":{"rendered":"https:\/\/trak.in\/stories\/?p=1299955"},"modified":"2025-09-08T07:16:08","modified_gmt":"2025-09-08T01:46:08","slug":"russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix","status":"publish","type":"post","link":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/","title":{"rendered":"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix"},"content":{"rendered":"\n

Russia has unveiled a groundbreaking development in oncology with Enteromix<\/em>, a personalized mRNA-based cancer vaccine that demonstrated 100% efficacy and safety in clinical trials. Unlike chemotherapy or radiation, this vaccine trains the immune system to recognize and destroy cancer cells, offering a more precise and side-effect-free treatment.<\/p>\n\n\n\n

\"Russian<\/figure>\n\n\n\n

How the Vaccine Works<\/h3>\n\n\n\n

Enteromix uses technology similar to COVID-19 vaccines, leveraging messenger RNA to create an immune response. It is tailored for each patient, ensuring that the vaccine targets specific tumor markers in the body. Moreover, it employs four harmless viruses to attack cancerous tumors and stimulate the body\u2019s natural defenses.<\/p>\n\n\n\n

Clinical Trials and Results<\/h3>\n\n\n\n

Earlier trials involved 48 volunteers under the supervision of Russia\u2019s National Medical Research Radiology Centre and the Engelhardt Institute of Molecular Biology. Results showed complete tumor shrinkage in several cases without major side effects, making it a promising alternative to conventional cancer therapies. Patients tolerated the vaccine well, a significant advantage over chemotherapy and radiation.<\/p>\n\n\n\n

Global Implications<\/h3>\n\n\n\n

The success of Enteromix could mark a turning point in cancer treatment globally. If approved, it will become the world\u2019s first personalized mRNA cancer vaccine available for public use. Experts believe it could save thousands of lives by offering safer, more effective treatment options and reducing dependency on invasive therapies.<\/p>\n\n\n\n

Awaiting Regulatory Approval<\/h3>\n\n\n\n

The vaccine has completed trials and now awaits final clearance from Russia\u2019s Ministry of Health. Once approved, it could soon be rolled out to patients across Russia before expanding globally. Medical experts are already hailing it as a potential revolution in oncology, with expectations that it will accelerate further innovation in personalized cancer therapies.<\/p>\n\n\n\n

Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Russia has unveiled a groundbreaking development in oncology with Enteromix, a personalized mRNA-based cancer vaccine that demonstrated 100% efficacy and safety in clinical trials. Unlike chemotherapy or radiation, this vaccine trains the immune system to recognize and destroy cancer cells, offering a more precise and side-effect-free treatment. How the Vaccine Works Enteromix uses technology similar […]<\/p>\n","protected":false},"author":30,"featured_media":1299959,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[401],"tags":[3557,8647,8648,8649],"class_list":["post-1299955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","tag-cancer","tag-cancer-druf","tag-drug","tag-enteromix"],"acf":[],"yoast_head":"\nRussian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix - Trak.in - Indian Business of Tech, Mobile & Startups<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix - Trak.in - Indian Business of Tech, Mobile & Startups\" \/>\n<meta property=\"og:description\" content=\"Russia has unveiled a groundbreaking development in oncology with Enteromix, a personalized mRNA-based cancer vaccine that demonstrated 100% efficacy and safety in clinical trials. Unlike chemotherapy or radiation, this vaccine trains the immune system to recognize and destroy cancer cells, offering a more precise and side-effect-free treatment. How the Vaccine Works Enteromix uses technology similar […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/\" \/>\n<meta property=\"og:site_name\" content=\"Trak.in - Indian Business of Tech, Mobile & Startups\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-08T01:43:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-08T01:46:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"914\" \/>\n\t<meta property=\"og:image:height\" content=\"554\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mohul Ghosh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mohul Ghosh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/\",\"url\":\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/\",\"name\":\"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix - Trak.in - Indian Business of Tech, Mobile & Startups\",\"isPartOf\":{\"@id\":\"https:\/\/trak.in\/stories\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png\",\"datePublished\":\"2025-09-08T01:43:12+00:00\",\"dateModified\":\"2025-09-08T01:46:08+00:00\",\"author\":{\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\"},\"breadcrumb\":{\"@id\":\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#primaryimage\",\"url\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png\",\"contentUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png\",\"width\":914,\"height\":554},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/trak.in\/stories\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/trak.in\/stories\/#website\",\"url\":\"https:\/\/trak.in\/stories\/\",\"name\":\"Trak.in - Indian Business of Tech, Mobile & Startups\",\"description\":\"Trak.in is a popular Indian Business, Technology, Mobile & Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups & Social Media Space\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/trak.in\/stories\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\",\"name\":\"Mohul Ghosh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"caption\":\"Mohul Ghosh\"},\"url\":\"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix - Trak.in - Indian Business of Tech, Mobile & Startups","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/","og_locale":"en_US","og_type":"article","og_title":"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix - Trak.in - Indian Business of Tech, Mobile & Startups","og_description":"Russia has unveiled a groundbreaking development in oncology with Enteromix, a personalized mRNA-based cancer vaccine that demonstrated 100% efficacy and safety in clinical trials. Unlike chemotherapy or radiation, this vaccine trains the immune system to recognize and destroy cancer cells, offering a more precise and side-effect-free treatment. How the Vaccine Works Enteromix uses technology similar […]","og_url":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/","og_site_name":"Trak.in - Indian Business of Tech, Mobile & Startups","article_published_time":"2025-09-08T01:43:12+00:00","article_modified_time":"2025-09-08T01:46:08+00:00","og_image":[{"width":914,"height":554,"url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png","type":"image\/png"}],"author":"Mohul Ghosh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mohul Ghosh","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/","url":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/","name":"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix - Trak.in - Indian Business of Tech, Mobile & Startups","isPartOf":{"@id":"https:\/\/trak.in\/stories\/#website"},"primaryImageOfPage":{"@id":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#primaryimage"},"image":{"@id":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#primaryimage"},"thumbnailUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png","datePublished":"2025-09-08T01:43:12+00:00","dateModified":"2025-09-08T01:46:08+00:00","author":{"@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7"},"breadcrumb":{"@id":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#primaryimage","url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png","contentUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png","width":914,"height":554},{"@type":"BreadcrumbList","@id":"https:\/\/trak.in\/stories\/russian-cancer-drug-achieves-100-efficacy-in-clinical-trials-enteromix\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/trak.in\/stories\/"},{"@type":"ListItem","position":2,"name":"Russian Cancer Drug Achieves 100% Efficacy In Clinical Trials: Enteromix"}]},{"@type":"WebSite","@id":"https:\/\/trak.in\/stories\/#website","url":"https:\/\/trak.in\/stories\/","name":"Trak.in - Indian Business of Tech, Mobile & Startups","description":"Trak.in is a popular Indian Business, Technology, Mobile & Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups & Social Media Space","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/trak.in\/stories\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7","name":"Mohul Ghosh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","caption":"Mohul Ghosh"},"url":"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/"}]}},"jetpack_featured_media_url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/09\/Screenshot-2025-09-08-at-7.12.30\u202fAM.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1299955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/comments?post=1299955"}],"version-history":[{"count":1,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1299955\/revisions"}],"predecessor-version":[{"id":1299960,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1299955\/revisions\/1299960"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media\/1299959"}],"wp:attachment":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media?parent=1299955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/categories?post=1299955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/tags?post=1299955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}